We are focused on connecting innovation to purpose.
Corbus is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin 4-on cancer cells to release a cytotoxic payload and CRB-601, and anti-integrin monoclonal antibody which blocks the activation of TGFβ expressed on cancer cells.
Corbus is based in Norwood, Massachusetts.
Corbus Values: What is at our C.O.R.E?
Recognize the power of diversity and inclusion. Welcome the differences within in us all; that’s what makes us shine as a team.
Own your compassion
Share in the journey. Experience the reality of patients, care partners, advocates and health care providers. We are not spectators but passionate, present individuals who thrive on participation.
Relentlessly transform Corbus
Continuously push for what is possible. Adapt and evolve in every aspect of our work. In the pursuit of bettering the lives of individuals, agile, purposeful change is needed.
Embrace your inner pioneer
Challenge the status quo. Innovate in the face of adversity and inspire the world around you…early and often. In order to progress we must be ambitious and goal-driven in our pursuits.